Allurion Technologies Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Allurion Technologies Inc
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world’s first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
/ 
Frequently asked questions
To buy Allurion Technologies Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Allurion Technologies Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Allurion Technologies Inc is ALUR:xnys. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Allurion Technologies Inc has its primary listing on New York Stock Exchange. You can trade Allurion Technologies Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Allurion Technologies Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Allurion Technologies Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Allurion Technologies Inc.